This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Vajdic CM, van Leeuwen MT . What types of cancers are associated with immune suppression in HIV? Lessons from solid organ transplant recipients. Curr Opin HIV AIDS 2009; 4: 35–41.
Law GR . Invited commentary: do clusters of leukemia and lymphoma provide evidence for an infectious cause? Am J Epidemiol 2005; 162: 823–824.
Ben-Bassat I, Raanani P, Gale RP . Graft-versus-leukemia in chronic lymphocytic leukemia. Bone Marrow Transplant 2007; 39: 441–446.
Ritgen M, Bottcher S, Stilgenbauer S, Bunjes D, Schubert J, Cohen S et al. Quantitative MRD monitoring identifies distinct GVL response patterns after allogeneic stem cell transplantation for chronic lymphocytic leukemia: results from the GCLLSG CLL3X trial. Leukemia 2008; 22: 1377–1386.
Krackhardt AM, Witzens M, Harig S, Hodi FS, Zauls AJ, Chessia M et al. Identification of tumor-associated antigens in chronic lymphocytic leukemia by SEREX. Blood 2002; 100: 2123–2131.
Khouri IF, Saliba RM, Admirand J, O’Brien S, Lee MS, Korbling M et al. Graft-versus-leukaemia effect after non-myeloablative haematopoietic transplantation can overcome the unfavourable expression of ZAP-70 in refractory chronic lymphocytic leukaemia. Br J Haematol 2007; 137: 355–363.
Penn DJ, Damjanovich K, Potts WK . MHC heterozygosity confers a selective advantage against multiple-strain infections. Proc Natl Acad Sci USA 2002; 99: 11260–11264.
Thursz MR, Thomas HC, Greenwood BM, Hill AV . Heterozygote advantage for HLA class-II type in hepatitis B virus infection. Nat Genet 1997; 17: 11–12.
Doherty PC, Zinkernagel RM . Enhanced immunological surveillance in mice heterozygous at the H-2 gene complex. Nature 1975; 256: 50–52.
Therodorou I, Abel L, Mauro F, Duprey B, Magnac C, Payelle-Brogard B et al. High occurrence of DRB1 11 in chronic lymphocytic leukaemia families. Br J Haematol 2002; 119: 713–715.
Hojjat-Farsangi M, Jeddi-Tehrani M, Amirzargar A, Razavi SM, Sharifian RA, Rabbani H et al. Human leukocyte antigen class II allele association to disease progression in Iranian patients with chronic lymphocytic leukemia. Hum Immunol 2008; 69: 666–674.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Shah, N., Decker, W., Lapushin, R. et al. HLA homozygosity and haplotype bias among patients with chronic lymphocytic leukemia: implications for disease control by physiological immune surveillance. Leukemia 25, 1036–1039 (2011). https://doi.org/10.1038/leu.2011.30
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2011.30
This article is cited by
-
Reduced intensity conditioning regimens including alkylating chemotherapy do not alter survival outcomes after allogeneic hematopoietic cell transplantation in chronic lymphocytic leukemia compared to low-intensity non-myeloablative conditioning
Journal of Cancer Research and Clinical Oncology (2019)
-
Pretransplant HLA mistyping in diagnostic samples of acute myeloid leukemia patients due to acquired uniparental disomy
Leukemia (2012)